High drug prices due to unreasonable margins of companies: CCI
The CCI also prescribed various ways to reduce the anti-trade practices in the policy paper.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Pharmaceuticals